Literature DB >> 19744852

Description of the national situation of cervical cancer screening in the member states of the European Union.

Ahti Anttila1, Guglielmo Ronco.   

Abstract

This report up-dates information on the national situation of cervical cancer screening in the member states of the European Union. There is yet high diversity in the status of cervical screening, and rapid changes expected to occur in the situation in many countries. It is important to underline differences in the health care and other components in order to allow a proper interpretation of the summary results published elsewhere in this Special Issue. The brief national descriptions along with up-dated information on the recent references are available from all but one member states.

Entities:  

Mesh:

Year:  2009        PMID: 19744852     DOI: 10.1016/j.ejca.2009.07.017

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  25 in total

1.  [Cervical cancer screening in Germany. Current status].

Authors:  V Schneider
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

Review 2.  Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan.

Authors:  Hideyuki Ishida; Yusuke Tajima; Tsuyoshi Gonda; Kensuke Kumamoto; Keiichiro Ishibashi; Takeo Iwama
Journal:  Surg Today       Date:  2016-01-08       Impact factor: 2.549

3.  The education gradient in cancer screening participation: a consistent phenomenon across Europe?

Authors:  Barbara Willems; Piet Bracke
Journal:  Int J Public Health       Date:  2017-10-23       Impact factor: 3.380

4.  Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

Authors:  Silvia de Sanjose; Cosette M Wheeler; Wim G V Quint; William C Hunt; Nancy E Joste; Laia Alemany; F Xavier Bosch; Evan R Myers; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-30       Impact factor: 4.254

5.  Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Authors:  Rémi Marty; Stéphane Roze; Xavier Bresse; Nathalie Largeron; Jayne Smith-Palmer
Journal:  BMC Cancer       Date:  2013-01-08       Impact factor: 4.430

6.  Cervical cancer in the screening era: who fell victim in spite of successful screening programs?

Authors:  B Folke Pettersson; Kristina Hellman; Roxane Vaziri; Sonia Andersson; Ann-Cathrin Hellström
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

7.  Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.

Authors:  Alice Kivistik; Katrin Lang; Paolo Baili; Ahti Anttila; Piret Veerus
Journal:  BMC Womens Health       Date:  2011-09-28       Impact factor: 2.809

8.  HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania.

Authors:  Ramona Gabriela Ursu; Mircea Onofriescu; Dragoş Nemescu; Luminiţa-Smaranda Iancu
Journal:  Virol J       Date:  2011-12-22       Impact factor: 4.099

9.  When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance.

Authors:  Fatima Azerkan; Catarina Widmark; Pär Sparén; Elisabete Weiderpass; Per Tillgren; Elisabeth Faxelid
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

10.  Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.

Authors:  Ellinor Östensson; Maria Fröberg; Amy Leval; Ann-Cathrin Hellström; Magnus Bäcklund; Niklas Zethraeus; Sonia Andersson
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.